Key result
Genistein pretreatment improves postischemic contractile recovery and total muscle economy in rat hearts.
Why the study?
Does genistein protect against cardiac stunning and energetic dysfunction following low-flow ischemia and reperfusion in rat hearts?
Does genistein protect against cardiac stunning and energetic dysfunction following low-flow ischemia and reperfusion in rat hearts?
This preclinical study demonstrates that systemic administration of genistein protects the heart from ischemia-reperfusion injury, likely through activation of mitochondrial KATP channels.
Genistein pretreatment may aid postischemic recovery in rats; leaves open human translation and optimal regimens.
Objectives Low-flow ischemia (LFI) is consequent to coronary disease and produces cardiac stunning during reperfusion (R). Energetic performance and mechanisms of Ca2+ handling during LFI/R are not known. Moreover, cardioprotection of the phytoestrogen genistein (Gen) remains to be demonstrated in LFI/R. The aim was to study the mechanisms of the stunning consequent to LFI/R and the effects of Gen on both sexes. Methods Rat ventricles were perfused inside a calorimeter to measure maximal pressure development (P) and total heat rate (Ht) before and during exposition to LFI/R. The mechanisms of stunning were evaluated with selective drugs. Key findings Female hearts (FH) developed higher postischemic contractile recovery (PICR) and muscle economy (P/Ht) than males (MH). Cardioprotection was sensitive to blockade of mKATP channels, UCam and NOS. Perfusion of 20 μmol/l Gen reduced PICR and P/Ht during LFI/R in FH, and dysfunction was increased by mNCX blockade with mPTP opening. However, intraperitoneal 5 mg/kg Gen (Gen-ip) was cardioprotective in both sexes, and the beneficial effect of Gen-ip was blocked by 100 μmol/l 5-HD. Conclusions FH are more protected than MH against the LFI/R dysfunction, which involves mitochondrial Ca2+ loss; Gen-ip was more cardioprotective in MH than in FH, mainly by activation of the mKATP channels.
No takes yet. Share an insight, caveat, or question.
Colareda et al. (2018) studied Low-flow ischemia/reperfusion injury (n=91). Genistein vs. Control (untreated/vehicle Krebs solution) was evaluated on Postischemic contractile recovery (PICR) (p=<0.05). Intraperitoneal genistein (5 mg/kg) administered 24 hours prior to ischemia significantly improved postischemic contractile recovery and total muscle economy in both male and female rat hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: